26 settembre 2017 Radioterapia

First use of gating techniques with active scanning proton therapy in Trento

A big step towards successful treatment of moving targets at the Proton Therapy Center in Trento
 
Trento, Italy, September 26 2017 - The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA, the world’s leading provider of proton therapy solutions for the treatment of cancer, announce the successful completion of the first gated treatment at the Proton Therapy Center in Trento.
 
For the first time, the clinical team in Trento completed a gated treatment for a patient affected by unresectable thymoma. They delivered active scanning proton therapy by synchronizing the proton beams with the patient respiratory cycle. This technique was performed through real time tracking of the patient’s respiratory motion, without any use of physical marker (Vision RT ®). The technology of Vision RT ® tracks the patient’s 3D surface in real time, which enhances patient comfort and safety, and improves the efficiency of the treatment by the clinical team.
GateCT® was used to track the patient’s breathing during the CT scanning and thereby enabling 4DCT acquisition and reconstruction. The evaluation of the interplay effect for a free-breathing treatment is performed using the different phases of the 4DCT.
During treatment delivery, accurate gating was ensured, allowing automatic beam hold when the breathing amplitude was higher than the one measured during the 4DCT scan.
 
Dr. Maurizio Amichetti, MD, Clinical Director of the Proton Therapy Center, commented: “This is a big step towards the full implementation of moving-target treatments with pencil beam scanning in our center. The moving-target project team leaders, Dr Francesco Dionisi, MD and Dr Francesco Fracchiolla, M.Sc., reported impressive results in terms of treatment feasibility and efficacy. We are really proud to improve every day with the goal of translating research projects in a clinical benefit for our patients”.
 
Anne Peters, Executive Vice President at IBA added: “At IBA, developing solutions that are clinically significant for the patients and that ease the work of our customers in their clinical practice is our priority. Many patients benefit from the complete solution that we offer for effective treatment of the moving-targets.”

News

22/05/2018 News

Piattaforma per l’analisi e la comparazione delle immagini di tomosintesi della mammella”: il 28 maggio al CRO l’evento finale di progetto

Si terrà lunedì 28 maggio al CRO – Centro di Riferimento Oncologico di Aviano l’evento di presentazione finale del progetto “Piattaforma per l’analisi e la comparazione delle immag [...]

21/05/2018 News

Strong uptake of RayStation Monte Carlo dose engine among proton therapy centers

13 out of 18 RayStation proton sites in clinical operation are now using the proton Monte Carlo (MC) dose engine, and this just a year after it was released. That according to a survey. “The implementation of th [...]

08/05/2018 Radioterapia

AL VIA IL NUOVO PROTON CENTER ALLO IEO DI MILANO

Tecnologie Avanzate è lieta di annunciare che giovedì 3 maggio è stato firmato l'accordo tra lo IEO - Istituto Europeo di Oncologia di Milano e la IBA (Ion Beam Applications, S.A, Euronext) per [...]

Eventi

20gen2017 | Eventi

RayCare Symposium, Roma 26 gennaio 2017

Tecnologie Avanzate è lieta di comunicare che il 26 gennaio organizza a Roma il primo RayCare Symposium, un incontro destinato a presentare in [...]

24mag2018 | Medicina nucleare

Corso Nazionale AIMN, Bergamo, 24-26 maggio 2018

Tecnologie Avanzate sarà sponsor del Corso Nazionale AIMN che avrà luogo a Bergamo il 24-26 maggio 2018.

Video gallery